News
Sign up for updates
Contact Us
Trials
If you are interested in participating or learning about future trials, then please complete the form on our contact page or contact the team at trials@exsurgo.com.
For sales enquiries and trials outside Auckland
For all other trials and sales enquiries please contact the team at enquiries@exsurgo.com.
Media
For all media enquires please contact the team at pr@exsurgo.com with your contact details and request. Images and video of the Axon product are available upon request.
Filter
Neuroscience company Exsurgo announces Jiva Muthu as COO
New Zealand neuroscience company Exsurgo has appointed experienced senior engineering executive, Jiva Muthu as Chief Operating Officer. Muthu joins Exsurgo from Rakon – one of the world’s la…
READJune 16, 2021
Making [brain] waves in the UK by Richard Little, CEO, Exsurgo
At Exsurgo, our vision is to unlock the power of neuroscience to ease suffering and enhance human potential. We’re on a mission to transform the way the world treats neurological problems with effec…
READJune 10, 2021
New Zealand neuroscience company Exsurgo announces success of breakthrough chronic pain management trial, UK study paves the way for larger clinical trial due to start soon in NZ
A recent UK study has confirmed the exciting potential of a breakthrough treatment for chronic pain management developed by neuroscience company, Exsurgo. Chronic pain (defined as pain that persists f…
READJune 3, 2021
Exsurgo announces John Emson as new CFO
Exsurgo has appointed experienced financial executive John Emson as its first Chief Financial Officer. Emson, who has spent over 30 years in finance and M&A across the technology, manufacturing, h…
READMay 7, 2021
Exsurgo CTO Faisal Almesfer co-authors paper on stroke rehabilitation
Background: As many as 80% of stroke survivors experience upper limb (UL) disability. The strong relationships between disability, lost productivity, and ongoing healthcare costs mean reducing disabil…
READJune 17, 2020
Exsurgo announces UK clinical trial to transform the future of chronic pain management
Exsurgo has begun a potentially ground-breaking UK-based clinical trial to determine the effectiveness of Axon, a user-friendly neurofeedback product that treats the primary and secondary symptoms of …
READJune 15, 2020
